TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15039 · Aug 8

#python#adk#agent_samples#agents The Agent Development Kit (ADK) offers ready-made sample agents in Python and Java to help you quickly build AI-powered agents for various tasks, from simple chatbots to complex multi-agent workflows. It supports flexible design, letting you combine multiple specialized agents, use diverse tools, and create adaptable workflows. ADK also includes developer tools for easy testing, debugging, and deployment, and works well with Google’s AI models and other large language models. Using these samples can save you time and effort by providing practical examples and a strong foundation to develop your own intelligent agents efficiently. This helps you focus on your agent’s logic while ADK handles orchestration and scaling. https://github.com/google/adk-samples

Results

4 similar posts found

Search: #vets

当前筛选 #vets清除筛选
VetPlus Academy

@vetplusacademy · Post #1291 · 01/29/2026, 03:42 PM

¡Tu crecimiento profesional no se detiene! 📈 Estamos diseñando un espacio donde la teoría y la práctica se encuentran para fortalecer tus competencias clínicas. Guías descargables, sesiones en vivo y certificación mensual son solo el comienzo. Mantente conectado. Lo que viene superará tus expectativas ✨ 🌐 Visítanos: vetplusacademy.com 📲 WhatsApp: +58 414 5300397 #VetPlus#Vets#MedVet#EstudiantesVeterinaria#VetPlusUltra

VET's HUB ®

@vets_hub · Post #30255 · 12/07/2025, 03:32 AM

NEWS 🔻𝗪𝗲𝗶𝗴𝗵𝘁 𝗹𝗼𝘀𝘀 𝗱𝗿𝘂𝗴𝘀 𝗳𝗼𝗿 𝗰𝗮𝘁𝘀? 𝗖𝗼𝗺𝗽𝗮𝗻𝘆 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗶𝗺𝗽𝗹𝗮𝗻𝘁𝘀 𝗶𝗻 𝗰𝗮𝘁𝘀 #Okava_Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new #GLP_1 clinical weight loss study for cats. #MEOW_1, as the study is called, will look to use #OKV_119, a miniature implant, in cats which will deliver the GLP-1, continuously for up to six months. According to #Okava, MEOW-1 is the first-ever weight loss trial using this approach on household pets. Klotsman said the goal would be to file for #FDA approval for the product between 2027 and 2028, and the target is for the product to cost owners an out-of-pocket payment of around $100 per month. Read the full story 👇 https://abcnews.go.com/GMA/Wellness/weight-loss-drugs-cats-company-launches-clinical-trial/story?id=128054236 #feline#cats#pets#petobesity#petcare#okavapharmaceuticals#sanfrancisco#vets#petowners#veterinarians#dvm